Hoxworth Blood Center Celebrates 10 Years of FACT Accreditation
Hoxworth Blood Center at the University of Cincinnati (UC) is celebrating 10 years of FACT (Foundation of the Accreditation of Cellular Therapy) accreditation. The organization has been recognized for this achievement and for its dedication and commitment to high-quality stem cell transplantation and cellular therapy.
"Please join me in applauding our Cellular Therapy Team lead by Dr. Tom Leemhuis in achieving this milestone honor, said Ronald Sacher, MD, Hoxworth's director and a professor of medicine and pathology at the UC College of Medicine. "The hard work and dedication of this team is helping to advance medical treatment and save lives in the Tristate every day.
FACT is a non-profit corporation co-founded in 1994 by the International Society for Cellular Therapy (ISCT) and the American Society of Blood and Marrow Transplantation (ASBMT) for the purposes of voluntary inspection and accreditation in the field of cellular therapy. The major objective of FACT is to promote high-quality patient care and laboratory performance in the belief that a valid accreditation must assess clinical, collection, and the laboratory components of the field.
Accreditation is awarded after successful documentation of compliance with the current standards. A team of inspectors who are qualified by training and experience carry out on-site inspections. The inspection process is quality-oriented and follows the FDAs rules for current Good Tissue Practice (cGTP).
Hoxworth Blood Center was founded in 1938 and serves 31 hospitals in 17 counties in southwestern Ohio, Northern Kentucky and southeastern Indiana. Annually, Hoxworth collects more than 90,000 units of blood from local donors to help save the lives of patients in area hospitals.
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.